dr well tirzepatide has been shown to reduce body weight in obese patients that are both diabetic and non-diabetic. It was found that Tirzepatide could regulate food preference, as as reduce food intake Zepbound Before and After for

Hormonal Pathways GLP-1 receptor activation also affects broader hormonal networks

The most commonly reported side effects for both include: Nausea, particularly during dose escalation Vomiting Diarrhea or constipation Reduced appetite (which is also the intended mechanism) Fatigue in some patients These side effects are most pronounced early in treatment and during dose increases

Ensuring that blood sugar levels are well-regulated is crucial as consistently elevated blood sugar levels can lead to severe health complications

Although postoral glucose tolerance test glucose levels were unaffected, the AGM intervention significantly reduced fasting insulin levels and HOMA-IR, indicating improved insulin sensitivity compared with placebo